Nextech Invest, Ltd.

Investment Portfolio & 13F Holdings Analysis

About
CIK: 0001595430
Type: FundHoldings: 15Value: $430.3MLatest: 2025Q1

Nextech Invest, Ltd. is an institutional investment manager that filed its latest Form 13F for 2025Q1, reporting 15 holdings worth $0.4 billion. Form 13F filings provide transparency into the equity holdings of institutional investment managers with over $100 million in assets under management. This page displays the most recent portfolio holdings, allowing investors to track position changes, new investments, and portfolio composition.

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
15
Total Value
430282008
Accession Number
0001415889-25-013146
Form Type
13F-HR
Manager Name
Nextech-Invest
Data Enrichment
100% identified
15 identified0 unidentified

Holdings

15 positions • $430.3M total value
Manager:
Search and click to pin securities to the top
Revolution Medicines, Inc.
Shares:7.6M
Value:$268.8M
% of Portfolio:62.5% ($268.8M/$430.3M)
Tyra Biosciences, Inc.
Shares:4.1M
Value:$37.7M
% of Portfolio:8.8% ($37.7M/$430.3M)
Oric Pharmaceuticals, Inc.
Shares:5.3M
Value:$29.5M
% of Portfolio:6.9% ($29.5M/$430.3M)
Zymeworks Inc.
Shares:1.1M
Value:$13.3M
% of Portfolio:3.1% ($13.3M/$430.3M)
ARS Pharmaceuticals, Inc.
Shares:936.7K
Value:$11.8M
% of Portfolio:2.7% ($11.8M/$430.3M)
CARGO Therapeutics, Inc.
Shares:2.6M
Value:$10.8M
% of Portfolio:2.5% ($10.8M/$430.3M)
Relay Therapeutics, Inc.
Shares:3.8M
Value:$10.1M
% of Portfolio:2.3% ($10.1M/$430.3M)
ARVINAS, INC.
Shares:1.4M
Value:$9.9M
% of Portfolio:2.3% ($9.9M/$430.3M)
ALUMIS INC.
Shares:1.5M
Value:$9.1M
% of Portfolio:2.1% ($9.1M/$430.3M)
Cullinan Therapeutics, Inc.
Shares:1.1M
Value:$8.6M
% of Portfolio:2.0% ($8.6M/$430.3M)
Tango Therapeutics, Inc.
Shares:5.5M
Value:$7.6M
% of Portfolio:1.8% ($7.6M/$430.3M)
Context Therapeutics Inc.
Shares:7.4M
Value:$4.5M
% of Portfolio:1.1% ($4.5M/$430.3M)
Mersana Therapeutics, Inc.
Shares:12.1M
Value:$4.2M
% of Portfolio:1.0% ($4.2M/$430.3M)
Silence Therapeutics plc
Shares:952.4K
Value:$2.7M
% of Portfolio:0.6% ($2.7M/$430.3M)
Boundless Bio, Inc.
Shares:1.2M
Value:$1.9M
% of Portfolio:0.4% ($1.9M/$430.3M)